Literature DB >> 29185106

Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding.

Ayman Yosry Abd ElRahim1, Rabab Fouad1, Marwa Khairy1, Aisha Elsharkawy1, Waleed Fathalah2, Haytham Khatamish3, Omayma Khorshid4, Mona Moussa5, Moataz Seyam3.   

Abstract

BACKGROUND AND AIMS: Band ligation and propranolol are the current therapies for primary prevention of variceal bleeding. Carvedilol is a rising nonselective beta-blocker used for reducing portal pressure with favorable outcome. The aim of this study to assess the efficacy of carvedilol, propranolol, and band ligation for primary prevention of variceal bleeding based on the effect of each regimen on progression of Child score and portal hypertensive gastropathy after 1 year.
METHODS: The study included 264 cirrhotic patients with medium/large-sized varices who were candidates for primary prophylaxis of variceal bleeding. Patients were randomly divided into three groups: group I: band ligation; group II: propranolol; group III: carvedilol.
RESULTS: Group I showed higher success rate of 75 %, followed by group III with 70.2 % and group II with 65.2 %. Risk of bleeding was comparable between the three groups, with group II carrying the highest rate of complications (34.7 %) followed by group III (14.2 %) and finally group I (5.7 %). After 1 year of follow-up, Child score did not improve in any of the studied groups, while portal hypertensive gastropathy significantly increased in group I but decreased in groups II and III.
CONCLUSIONS: Band ligation is the best treatment option for primary prevention of variceal bleeding with minimal complications. Carvedilol is a good pharmaceutical alternative medicine to propranolol with lesser side-effects. Progress of liver disease as represented by Child score is not affected by any of the primary variceal prophylactic regimens, although medical treatment reduces portal hypertensive gastropathy. Choice of treatment depends on patient will, compliance with treatment, and endoscopist competence.

Entities:  

Keywords:  Band ligation; Carvedilol; Portal hypertension; Primary prophylaxis; Propranolol; Varices

Mesh:

Substances:

Year:  2017        PMID: 29185106     DOI: 10.1007/s12072-017-9835-9

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  21 in total

1.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

Review 2.  The management of portal hypertension: rational basis, available treatments and future options.

Authors:  Jaime Bosch; Annalisa Berzigotti; Juan Carlos Garcia-Pagan; Juan G Abraldes
Journal:  J Hepatol       Date:  2008-02-12       Impact factor: 25.083

3.  Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is...

Authors:  Jaime Bosch; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

4.  A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation.

Authors:  Lorenzo Norberto; Lino Polese; Umberto Cillo; Francesco Grigoletto; Andrew K Burroughs; Daniele Neri; Giacomo Zanus; Patrizia Boccagni; Patrizia Burra; Davide F D'Amico
Journal:  Liver Transpl       Date:  2007-09       Impact factor: 5.799

5.  Endoscopic variceal ligation vs. propranolol for prevention of first variceal bleeding: a randomized controlled trial.

Authors:  Dimitrios Psilopoulos; Petros Galanis; Spyros Goulas; Ioannis S Papanikolaou; Ioannis Elefsiniotis; Christos Liatsos; Loukas Sparos; Christos Mavrogiannis
Journal:  Eur J Gastroenterol Hepatol       Date:  2005-10       Impact factor: 2.566

Review 6.  Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension.

Authors:  Jaume Bosch; Juan G Abraldes; Mercedes Fernández; Juan Carlos García-Pagán
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

7.  Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.

Authors:  Dhiraj Tripathi; James W Ferguson; Narendra Kochar; Joanna A Leithead; George Therapondos; Norma C McAvoy; Adrian J Stanley; Ewan H Forrest; William S Hislop; Peter R Mills; Peter C Hayes
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

8.  Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.

Authors:  J C García-Pagán; C Villanueva; A Albillos; R Bañares; R Morillas; J G Abraldes; J Bosch
Journal:  Gut       Date:  2009-02-12       Impact factor: 23.059

9.  A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage.

Authors:  Anna V Longacre; Avlin Imaeda; Guadalupe Garcia-Tsao; Liana Fraenkel
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

Review 10.  Carvedilol in the treatment of portal hypertension.

Authors:  Hamdan Al-Ghamdi
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

View more
  11 in total

1.  Primary prophylaxis of variceal bleeding.

Authors:  Marcus Robertson; Peter Hayes
Journal:  Hepatol Int       Date:  2018-02-02       Impact factor: 6.047

2.  Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.

Authors:  Davide Roccarina; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Amine Benmassaoud; Maria Corina Plaz Torres; Laura Iogna Prat; Mario Csenar; Sivapatham Arunan; Tanjia Begum; Elisabeth Jane Milne; Maxine Tapp; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Norman R Williams; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-04-06

3.  Carvedilol vs endoscopic variceal ligation for primary and secondary prevention of variceal bleeding: Systematic review and meta-analysis.

Authors:  Michael Dwinata; David Dwi Putera; Muhamad Fajri Adda'i; Putra Nur Hidayat; Irsan Hasan
Journal:  World J Hepatol       Date:  2019-05-27

4.  Carvedilol for prevention of variceal bleeding: a systematic review and meta-analysis.

Authors:  Konstantinos Malandris; Paschalis Paschos; Anastasia Katsoula; Apostolos Manolopoulos; Panagiotis Andreadis; Maria Sarigianni; Eleni Athanasiadou; Evangelos Akriviadis; Apostolos Tsapas
Journal:  Ann Gastroenterol       Date:  2019-03-12

Review 5.  Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis.

Authors:  Shan Tian; Ruixue Li; Yingyun Guo; Xuemei Jia; Weiguo Dong
Journal:  Ther Clin Risk Manag       Date:  2019-01-29       Impact factor: 2.423

Review 6.  Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension.

Authors:  Zhen-Gang Wei; Feng-Xian Wei; Zi-Wei Shao; Guo-Hong Su; Xue-Ping Qi; You-Cheng Zhang
Journal:  Ther Clin Risk Manag       Date:  2018-12-24       Impact factor: 2.423

7.  KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2020-01-10

Review 8.  Beta-blockers in cirrhosis: Evidence-based indications and limitations.

Authors:  Susana G Rodrigues; Yuly P Mendoza; Jaime Bosch
Journal:  JHEP Rep       Date:  2019-12-20

Review 9.  Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.

Authors:  Antony P Zacharias; Rebecca Jeyaraj; Lise Hobolth; Flemming Bendtsen; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29

Review 10.  Evidence-based clinical practice guidelines for Liver Cirrhosis 2020.

Authors:  Hitoshi Yoshiji; Sumiko Nagoshi; Takemi Akahane; Yoshinari Asaoka; Yoshiyuki Ueno; Koji Ogawa; Takumi Kawaguchi; Masayuki Kurosaki; Isao Sakaida; Masahito Shimizu; Makiko Taniai; Shuji Terai; Hiroki Nishikawa; Yoichi Hiasa; Hisashi Hidaka; Hiroto Miwa; Kazuaki Chayama; Nobuyuki Enomoto; Tooru Shimosegawa; Tetsuo Takehara; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-07-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.